These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7584794)

  • 21. [Fibrinogen: a "new" cardiovascular risk factor].
    Ernst E
    Wien Med Wochenschr; 1991; 141(17):375-82. PubMed ID: 1771915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fibrinogen. Cardiovascular risk factor or marker?].
    Canseco-Avila LM; Jerjes-Sánchez C; Ortiz-López R; Rojas-Martínez A; Guzmán-Ramírez D
    Arch Cardiol Mex; 2006; 76 Suppl 4():S158-72. PubMed ID: 17469344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study.
    Palmieri V; Celentano A; Roman MJ; de Simone G; Best L; Lewis MR; Robbins DC; Fabsitz RR; Howard BV; Devereux RB;
    Am Heart J; 2003 Mar; 145(3):467-74. PubMed ID: 12660670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
    Gensini GF; Comeglio M; Colella A
    Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of age and glycaemic control on the association between fibrinogen and risk of acute coronary events after transient ischaemic attack or stroke.
    Howard SC; Algra A; Rothwell PM;
    Cerebrovasc Dis; 2008; 25(1-2):136-43. PubMed ID: 18073467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fibrinogen as a cardiovascular risk factor].
    Giannasi G; Ferrari S; Galetta F
    Minerva Cardioangiol; 1995 May; 43(5):169-75. PubMed ID: 7478039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study.
    Welsh P; Woodward M; Rumley A; Lowe G
    Br J Haematol; 2008 Jun; 141(6):852-61. PubMed ID: 18371109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
    Catena C; Cavarape A; Dotto L; Colussi G; Novehllo M; De Marchi S; Sechi LA
    Adv Clin Path; 2003 Jan; 7(1):3-11. PubMed ID: 19774732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasma fibrinogen as a cardiovascular risk factor].
    Naito M; Hayashi T; Iguchi A
    Nihon Ronen Igakkai Zasshi; 1994 Mar; 31(3):213-8. PubMed ID: 8207872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemostatic factors and risk of cardiovascular disease in women. An overview.
    Meilahn EN
    Arch Pathol Lab Med; 1992 Dec; 116(12):1313-7. PubMed ID: 1456877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemostatic factors and coronary heart disease.
    Pilgeram LO
    Biomed Pharmacother; 1982; 36(4):187-9. PubMed ID: 7165789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etiopathogenesis of cardiovascular disease: hemostasis, thrombosis, and vascular medicine.
    Lowe GD
    Ann Periodontol; 1998 Jul; 3(1):121-6. PubMed ID: 9722696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fibrinogen seen as an independent cardiovascular factor from the molecular aspect].
    Dyr JE; Suttnar J; Fortová H; Cajthamlová H
    Cas Lek Cesk; 1992 Dec; 131(24-25):733-6. PubMed ID: 1288874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The significance of rheologic mechanisms in atherogenesis].
    Leschke M; Strauer BE
    Arzneimittelforschung; 1990 Mar; 40(3A):356-62. PubMed ID: 2185764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on fibrinogen as a cardiovascular risk factor.
    Kannel WB; D'Agostino RB; Belanger AJ
    Ann Epidemiol; 1992 Jul; 2(4):457-66. PubMed ID: 1342296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinogen and risk of cardiovascular disease. The Framingham Study.
    Kannel WB; Wolf PA; Castelli WP; D'Agostino RB
    JAMA; 1987 Sep; 258(9):1183-6. PubMed ID: 3626001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrin(ogen) in cardiovascular disease: an update.
    Koenig W
    Thromb Haemost; 2003 Apr; 89(4):601-9. PubMed ID: 12669113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking, haemostatic factors, and cardiovascular risk.
    Leone A
    Curr Pharm Des; 2007; 13(16):1661-7. PubMed ID: 17584096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.